Thanks so much – July & August '07 coversations on IP ThinkTank
IP ThinkTank is now 2 months old.
Thanks so much and thank you to the many people who have newly subscribed by email or RSS over the past two months.
Here are the four posts which generated the most discussion – please feel free to add your comments:
- Novartis’ glivec battle with India – patentability of pharmaceutical extension patents (17 comments);
- Lifecycle Management at risk? Will Asian countries follow India’s 3(d) lead? (6 comments);
I look forward to continuing the conversation in September and beyond.